Regulacje i polityka gospodarcza · 02/10/1996

NIST Announces Prospective Grant of Coexclusive Patent License for Liposome Immunoanalysis By Flow Injection Assay

The National Institute of Standards and Technology (NIST) is considering granting a coexclusive license to practice a specific patent to two companies, Pasadena Scientific Industries and Saddleback Aerospace Corporation, for the use of a technology related to liposome immunoanalysis by flow injection assay in the United States.